Homozygous Deficiency of Heparin Cofactor II: Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-09-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000140763.51679.D9PMID 15337701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention

  2004cited by this paper
• Drosophila necrotic mutations mirror disease-associated variants of human serpins

  2003cited by this paper
• Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism

  2002cited by this paper
• Alpha1-antitrypsin deficiency--a model for conformational diseases.

  2002cited by this paper
• Heparin cofactor II inhibits arterial thrombosis after endothelial injury.

  2002cited by this paper
• Heparin cofactor II deficiency.

  2002cited by this paper
• Molecular Mechanism of Type I Congenital Heparin Cofactor (HC) II Deficiency Caused by a Missense Mutation at Reactive P2 Site: HC II Tokushima

  2001cited by this paper
• Complete antithrombin deficiency in mice results in embryonic lethality.

  2000cited by this paper
• Thrombin signalling and protease-activated receptors

  2000cited by this paper
• Conformational disease

  2000cited by this paper
• Heparin cofactor II

  1999cited by this paper
• Hereditary Homozygous Heparin Cofactor II Deficiency and the Risk of Developing Venous Thrombosis

  1999cited by this paper
• [Heparin cofactor II deficiency].

  1998cited by this paper
• Conformational disease.

  1997cited by this paper
• Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).

  1996cited by this paper
• A Heparin Cofactor II Mutation (HCII Rimini) Combined with Factor V Leiden or Type I Protein C Deficiency in Two Unrelated Thrombophilic Subjects

  1996cited by this paper
• Molecular Basis of Thrombosis and Hemostasis

  1995cited by this paper
• What do dysfunctional serpins tell us about molecular mobility and disease?

  1995cited by this paper
• Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.

  1993cited by this paper
• Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11.

  1991cited by this paper
• [Heparin cofactor II].

  1990cited by this paper
• Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.

  1989cited by this paper
• Structure and expression of the gene coding for the human serpin hLS2.

  1988cited by this paper
• Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli.

  1988cited by this paper
• A new member of the plasma protease inhibitor gene family.

  1986cited by this paper

• Impaired SERPIN–Protease Balance in the Peripheral Lungs of Stable COPD Patients

  2025cites this paper
• Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery

  2022cites this paper
• Markers of Hereditary Thrombophilia with Unclear Significance

  2022cites this paper
• RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A

  2021cites this paper
• A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants

  2019cites this paper
• An analysis of plasma reveals proteins in the acute phase response pathway to be candidate diagnostic biomarkers for depression.

  2019cites this paper
• Heparinoids Danaparoid and Sulodexide as clinically used drugs.

  2019cites this paper
• Serpinopathies

  2019cites this paper
• Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula.

  2018cites this paper
• EL EQUILIBRIO HEMOSTÁTICO, UN PROCESO COMPLEJO

  2016cites this paper
• Genetic variants and evolutionary analyses of heparin cofactor II.

  2014cites this paper
• Thrombin inhibition by the serpins

  2013cites this paper
• Twenty Years of Polymers: A Personal Perspective on Alpha-1 Antitrypsin Deficiency

  2013cites this paper
• Common genetic risk factors for venous thrombosis in the Chinese population.

  2013cites this paper
• Recent Insights into the Molecular and Cellular Contributions to Venous Thrombosis

  2012cites this paper
• The structure and function of ZPI, and the role of ZPI deficiency in venous thrombosis

  2012cites this paper
• Type II antithrombin deficiency caused by a large in‐frame insertion: structural, functional and pathological relevance

  2012cites this paper
• Regulatory regions of SERPINC1 gene: Identification of the first mutation associated with antithrombin deficiency

  2012cites this paper
• Thrombophilia: Assays and Interpretation

  2012cites this paper
• Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.

  2011cites this paper
• Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.

  2011cites this paper
• Unravelling the twists and turns of the serpinopathies

  2011cites this paper
• Heparin Cofactor II: Discovery, Properties, and Role in Controlling Vascular Homeostasis

  2011cites this paper
• Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin.

  2010cites this paper
• Chapter 9 – Hemostatic Disorders Presenting as Cerebral Infarction

  2009cites this paper
• Conformational pathology of the serpins: themes, variations, and therapeutic strategies.

  2009cites this paper
• alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.

  2009cites this paper
• Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.

  2009cites this paper
• Residues in the Human Corticosteroid-binding Globulin Reactive Center Loop That Influence Steroid Binding before and after Elastase Cleavage*

  2009cites this paper
• Hematological diseases and stroke.

  2009cites this paper
• Engineering of serpins for vascular application

  2008cites this paper
• Polymers and inflammation: disease mechanisms of the serpinopathies

  2008cites this paper
• Protein Misfolding and the Serpinopathies

  2007cites this paper
• Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice.

  2007cites this paper
• Protein Z/Z‐dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis

  2007cites this paper
• Factors with conformational effects on haemostatic serpins: Implications in thrombosis

  2007cites this paper
• Trombofilia hereditaria: lecciones aprendidas y deberes pendientes

  2007cites this paper
• [Hereditary thrombophilia: learnt lessons and pending duties].

  2007cites this paper
• A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.

  2006cites this paper
• Sulodexide: a renewed interest in this glycosaminoglycan.

  2006influential citation
• Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease.

  2006cites this paper
• Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.

  2006cites this paper
• Molecular mousetraps and the serpinopathies.

  2005cites this paper
• Thrombosis as a conformational disease.

  2005cites this paper
• Tissue-Specific Hemostasis in Mice

  2005cites this paper
• Molecular mousetraps, α1-antitrypsin deficiency and the serpinopathies

  2005cites this paper
• Molecular mousetraps, alpha1-antitrypsin deficiency and the serpinopathies.

  2005cites this paper